Antisepsis with polyhexanide is effective against endophthalmitis after intravitreal injections.
Department of Ophthalmology, University Hospital of Cologne, Cologne, Germany.
Tina
T
Ristau
Bernd
B
Kirchhof
Sascha
S
Fauser
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000985:Antisepsis / Q000379:methods*; D001645:Biguanides / Q000627:therapeutic use*; D009877:Endophthalmitis / Q000382:microbiology / Q000517:prevention & control*; D015818:Eye Infections, Bacterial / Q000382:microbiology / Q000517:prevention & control*; D005500:Follow-Up Studies; D006801:Humans; D058449:Intravitreal Injections / Q000009:adverse effects*; D012189:Retrospective Studies; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors
D020533:Angiogenesis Inhibitors; D000900:Anti-Bacterial Agents; D001645:Biguanides; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; C031233:polihexanide